Effect of Second-Generation vs Third-Generation Chemotherapy Regimens With Thoracic Radiotherapy on Unresectable Stage III NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Second-Generation vs Third-Generation Chemotherapy Regimens With Thoracic Radiotherapy on Unresectable Stage III Non–Small-Cell Lung Cancer: 10-Year Follow-Up of a WJTOG0105 Phase 3 Randomized Clinical Trial
JAMA Oncol 2021 Mar 18;[EPub Ahead of Print], Y Zenke, M Tsuboi, Y Chiba, K Tsujino, M Satouchi, K Sawa, J Shimizu, H Daga, D Fujimoto, M Mori, T Aoki, T Sawa, S Omori, H Saka, Y Iwamoto, M Okuno, T Hirashima, K Kashiwabara, M Tachihara, N Ymamoto, K NakagawaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.